Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Matschke

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Journal of Physiology|November 7, 2012
Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intakeC I Nabuurs, C U Choe, A Veltien, et al.
Acta Neuropathologica Communications|April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and developmentH Binder, E Willscher, H Loeffler-Wirth, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2019
Sequence-dependent cross-resistance of combined radiotherapy plus BRAF<sup>V600E</sup> inhibition in melanomaB Shannan, J Matschke, H Chauvistré, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Journal of Physiology|November 7, 2012
Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intakeC I Nabuurs, C U Choe, A Veltien, et al.
Acta Neuropathologica Communications|April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and developmentH Binder, E Willscher, H Loeffler-Wirth, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2019
Sequence-dependent cross-resistance of combined radiotherapy plus BRAF<sup>V600E</sup> inhibition in melanomaB Shannan, J Matschke, H Chauvistré, et al.
Pageof 4